Element Biosciences partners with Agilent Technologies

By The Science Advisory Board staff writers

February 23, 2022 -- Element Biosciences has partnered with Agilent Technologies to demonstrate the integration of Element’s AVITI System with Agilent Technologies’ industry-leading SureSelect target enrichment panels, providing customers greater access to these genomic tools.

Target enrichment as a pre-sequencing DNA preparation method is invaluable for clinical and industrial applications where accuracy, cost-effectiveness, and throughput are critical. As a leader in hybridization-based target enrichment, Agilent’s SureSelect sequencing panels are highly sensitive and enable detection of single-nucleotide, structural, and copy number variants, fusions, insertions, and deletions.

Element’s avidity sequencing technology offers enhanced contrast-to-noise ratio (CNR) and inherent error suppression mechanism to produce scarless DNA products. The collaboration between the two companies demonstrates that Element’s technology can be seamlessly integrated into Agilent’s target enrichment technology.

Element Biosciences is a multi-disciplinary life science company currently focused on developing disruptive DNA sequencing technology for research and diagnostic markets.

Agilent acquires AI technology to enhance lab productivity
Agilent Technologies has acquired advanced artificial intelligence (AI) technology developed by Virtual Control, an AI and machine-learning software developer...
Top PE investments in biotools in 2021
2021 was an especially active year for private equity (PE) firms. According to PitchBook, the number of deals surged over 51% last year to top 8,600....
Agilent's Cary 3500 UV-Vis now compatible with OpenLab
Agilent Technologies' Cary 3500 UV-Vis spectrophotometer is now compatible with Agilent's OpenLab software. The update provides labs with the technical...

Copyright © 2022 scienceboard.net

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter